Simon Marc Helfgott, D.C.S., M.D.,C.M.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Rheumatoid | 19 | 2019 | 3780 | 0.710 |
Why?
|
Rheumatology | 3 | 2020 | 617 | 0.710 |
Why?
|
Chondrocalcinosis | 1 | 2017 | 84 | 0.520 |
Why?
|
Paraneoplastic Syndromes | 1 | 2017 | 154 | 0.510 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2015 | 97 | 0.460 |
Why?
|
Arthritis | 6 | 2008 | 684 | 0.450 |
Why?
|
Giant Cell Arteritis | 2 | 2015 | 307 | 0.410 |
Why?
|
Sjogren's Syndrome | 1 | 2014 | 241 | 0.410 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2014 | 716 | 0.380 |
Why?
|
Respiratory Tract Diseases | 1 | 2015 | 744 | 0.330 |
Why?
|
Education, Medical | 2 | 2020 | 1742 | 0.320 |
Why?
|
Joints | 2 | 2008 | 324 | 0.320 |
Why?
|
Medicine | 2 | 2010 | 947 | 0.310 |
Why?
|
Leukemia, Myelomonocytic, Acute | 1 | 2008 | 38 | 0.310 |
Why?
|
Leukemic Infiltration | 1 | 2008 | 47 | 0.300 |
Why?
|
Synovial Fluid | 2 | 2017 | 393 | 0.290 |
Why?
|
Serum Sickness | 1 | 2007 | 26 | 0.280 |
Why?
|
Myelodysplastic Syndromes | 1 | 2017 | 1399 | 0.280 |
Why?
|
Stiff-Person Syndrome | 2 | 1999 | 31 | 0.280 |
Why?
|
Lupus Erythematosus, Systemic | 3 | 2014 | 2171 | 0.270 |
Why?
|
Antirheumatic Agents | 5 | 2009 | 1381 | 0.250 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2006 | 588 | 0.240 |
Why?
|
Antibodies, Monoclonal | 3 | 2007 | 9264 | 0.240 |
Why?
|
Career Choice | 1 | 2010 | 769 | 0.230 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2007 | 240 | 0.230 |
Why?
|
Opportunistic Infections | 1 | 2007 | 375 | 0.230 |
Why?
|
Spondylarthropathies | 1 | 2023 | 14 | 0.220 |
Why?
|
Exanthema | 2 | 2023 | 503 | 0.210 |
Why?
|
Propylthiouracil | 1 | 2002 | 68 | 0.210 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 2023 | 83 | 0.200 |
Why?
|
Medical Staff | 1 | 2002 | 40 | 0.200 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3118 | 0.200 |
Why?
|
Isoxazoles | 2 | 2001 | 233 | 0.200 |
Why?
|
Antithyroid Agents | 1 | 2002 | 72 | 0.200 |
Why?
|
Synovitis | 4 | 1992 | 217 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.200 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 4 | 2001 | 2276 | 0.180 |
Why?
|
Etidronic Acid | 1 | 2000 | 63 | 0.180 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2002 | 297 | 0.170 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2007 | 843 | 0.170 |
Why?
|
Pandemics | 1 | 2020 | 8749 | 0.170 |
Why?
|
Telecommunications | 1 | 2020 | 79 | 0.170 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2009 | 4356 | 0.170 |
Why?
|
Alendronate | 1 | 2000 | 174 | 0.160 |
Why?
|
Calcitonin | 1 | 2000 | 329 | 0.160 |
Why?
|
Drug Substitution | 1 | 2021 | 291 | 0.150 |
Why?
|
Bone Marrow | 2 | 2008 | 2936 | 0.150 |
Why?
|
Vasculitis | 1 | 2002 | 525 | 0.150 |
Why?
|
Spondylitis, Ankylosing | 2 | 1990 | 159 | 0.150 |
Why?
|
Specialization | 1 | 2002 | 780 | 0.140 |
Why?
|
Education, Distance | 1 | 2020 | 260 | 0.130 |
Why?
|
Workplace | 1 | 2002 | 873 | 0.130 |
Why?
|
Polymyalgia Rheumatica | 1 | 1996 | 52 | 0.130 |
Why?
|
Lymphokines | 3 | 1988 | 927 | 0.130 |
Why?
|
Trismus | 1 | 2015 | 33 | 0.120 |
Why?
|
Immunoglobulin G | 2 | 2006 | 4568 | 0.120 |
Why?
|
Psoriasis | 1 | 2023 | 926 | 0.120 |
Why?
|
Blood Sedimentation | 1 | 1996 | 236 | 0.120 |
Why?
|
Arthritis, Experimental | 2 | 1988 | 293 | 0.120 |
Why?
|
Hormone Replacement Therapy | 1 | 2000 | 757 | 0.120 |
Why?
|
Immunoblastic Lymphadenopathy | 1 | 1994 | 40 | 0.120 |
Why?
|
Skin | 1 | 2008 | 4506 | 0.120 |
Why?
|
Butanones | 1 | 1994 | 23 | 0.120 |
Why?
|
Foot Diseases | 2 | 2002 | 148 | 0.110 |
Why?
|
Infarction | 1 | 2015 | 247 | 0.110 |
Why?
|
Osteoporosis | 2 | 2000 | 1606 | 0.110 |
Why?
|
Collagen | 5 | 1991 | 2646 | 0.100 |
Why?
|
Transaminases | 1 | 1993 | 199 | 0.100 |
Why?
|
Intermittent Claudication | 1 | 2015 | 305 | 0.100 |
Why?
|
Paralysis | 1 | 1993 | 250 | 0.100 |
Why?
|
Low Back Pain | 1 | 2001 | 990 | 0.100 |
Why?
|
Tongue | 1 | 2015 | 406 | 0.100 |
Why?
|
Edema | 2 | 2015 | 766 | 0.100 |
Why?
|
Herpes Zoster | 2 | 1993 | 252 | 0.100 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2017 | 977 | 0.090 |
Why?
|
Cough | 1 | 2015 | 598 | 0.090 |
Why?
|
Hearing Loss, Bilateral | 1 | 1991 | 53 | 0.090 |
Why?
|
Laryngeal Cartilages | 1 | 1990 | 23 | 0.090 |
Why?
|
Myositis | 1 | 1993 | 269 | 0.090 |
Why?
|
Diclofenac | 1 | 1990 | 69 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 1 | 2018 | 1813 | 0.090 |
Why?
|
Wrist | 1 | 1992 | 231 | 0.090 |
Why?
|
Humans | 45 | 2023 | 768970 | 0.090 |
Why?
|
Aged | 24 | 2019 | 171786 | 0.090 |
Why?
|
Immunoglobulins, Intravenous | 1 | 1994 | 667 | 0.080 |
Why?
|
Weight Loss | 1 | 2001 | 2721 | 0.080 |
Why?
|
Ligaments, Articular | 1 | 1992 | 308 | 0.080 |
Why?
|
Lymphatic Irradiation | 1 | 1989 | 115 | 0.080 |
Why?
|
Osteoarthritis | 2 | 1994 | 1070 | 0.080 |
Why?
|
Evidence-Based Medicine | 1 | 2001 | 3709 | 0.080 |
Why?
|
Health Personnel | 1 | 2002 | 3383 | 0.080 |
Why?
|
Salaries and Fringe Benefits | 1 | 2010 | 262 | 0.080 |
Why?
|
Hearing Loss | 1 | 2015 | 785 | 0.070 |
Why?
|
Interferon-alpha | 1 | 2012 | 910 | 0.070 |
Why?
|
Bursitis | 1 | 1988 | 85 | 0.070 |
Why?
|
Gangrene | 1 | 1987 | 92 | 0.070 |
Why?
|
Bone Density | 1 | 2000 | 3574 | 0.070 |
Why?
|
Cultural Diversity | 1 | 2010 | 373 | 0.070 |
Why?
|
Male | 31 | 2023 | 365203 | 0.070 |
Why?
|
Middle Aged | 24 | 2023 | 223737 | 0.070 |
Why?
|
Injections, Intra-Articular | 2 | 2007 | 288 | 0.070 |
Why?
|
Health Behavior | 1 | 2018 | 2649 | 0.070 |
Why?
|
Drug Therapy, Combination | 3 | 2007 | 6320 | 0.070 |
Why?
|
Diphosphonates | 2 | 1982 | 634 | 0.070 |
Why?
|
Pelvic Bones | 1 | 1988 | 274 | 0.070 |
Why?
|
Prednisolone | 1 | 2007 | 327 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2018 | 4413 | 0.060 |
Why?
|
Substance-Related Disorders | 1 | 2002 | 4423 | 0.060 |
Why?
|
Methylprednisolone | 1 | 2007 | 386 | 0.060 |
Why?
|
Technetium | 2 | 1982 | 326 | 0.060 |
Why?
|
Liver Diseases | 1 | 1993 | 1305 | 0.060 |
Why?
|
B-Lymphocytes | 2 | 2017 | 4794 | 0.060 |
Why?
|
Hearing Loss, Sensorineural | 1 | 1991 | 783 | 0.060 |
Why?
|
Eye | 1 | 2008 | 712 | 0.060 |
Why?
|
Immune Sera | 1 | 1984 | 605 | 0.060 |
Why?
|
Antineoplastic Agents | 1 | 2007 | 13698 | 0.060 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2007 | 696 | 0.060 |
Why?
|
Female | 29 | 2019 | 397515 | 0.050 |
Why?
|
Immunocompromised Host | 1 | 2009 | 863 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2008 | 13021 | 0.050 |
Why?
|
Skeleton | 1 | 1982 | 29 | 0.050 |
Why?
|
Antibodies | 1 | 1991 | 2422 | 0.050 |
Why?
|
Acute-Phase Proteins | 1 | 2003 | 252 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3110 | 0.050 |
Why?
|
Health Planning Guidelines | 1 | 2002 | 153 | 0.050 |
Why?
|
Fellowships and Scholarships | 1 | 2010 | 1134 | 0.050 |
Why?
|
Rheumatic Diseases | 1 | 2009 | 659 | 0.050 |
Why?
|
Antibiotic Prophylaxis | 1 | 2007 | 641 | 0.050 |
Why?
|
Acute Disease | 2 | 2023 | 7245 | 0.050 |
Why?
|
Hematologic Tests | 1 | 2002 | 239 | 0.050 |
Why?
|
Leukocytes, Mononuclear | 1 | 2008 | 1855 | 0.050 |
Why?
|
Formularies as Topic | 1 | 2021 | 94 | 0.050 |
Why?
|
Fatigue | 1 | 2008 | 1557 | 0.050 |
Why?
|
Densitometry | 1 | 2000 | 151 | 0.040 |
Why?
|
Dyspnea | 1 | 2008 | 1352 | 0.040 |
Why?
|
Hyperthyroidism | 1 | 2002 | 292 | 0.040 |
Why?
|
Pharmaceutical Services | 1 | 2021 | 143 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2001 | 501 | 0.040 |
Why?
|
Administration, Oral | 1 | 2007 | 4040 | 0.040 |
Why?
|
Australia | 1 | 2002 | 1265 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 1991 | 2258 | 0.040 |
Why?
|
C-Reactive Protein | 1 | 2009 | 3859 | 0.040 |
Why?
|
Neurologic Examination | 1 | 2001 | 916 | 0.040 |
Why?
|
Macrophage-Activating Factors | 1 | 2017 | 21 | 0.040 |
Why?
|
Pain | 2 | 2009 | 5100 | 0.040 |
Why?
|
Rats, Inbred WF | 2 | 1988 | 140 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2006 | 3744 | 0.040 |
Why?
|
Chronic Disease | 2 | 2023 | 9384 | 0.030 |
Why?
|
Chemokine CXCL13 | 1 | 2017 | 62 | 0.030 |
Why?
|
Republic of Korea | 1 | 2019 | 592 | 0.030 |
Why?
|
Receptors, CXCR5 | 1 | 2017 | 88 | 0.030 |
Why?
|
HLA-DR Antigens | 1 | 2018 | 609 | 0.030 |
Why?
|
Aspartate Aminotransferases | 2 | 1999 | 414 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 190 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 4207 | 0.030 |
Why?
|
Tuberculosis | 1 | 2009 | 2029 | 0.030 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2008 | 2251 | 0.030 |
Why?
|
Fibromyalgia | 2 | 2009 | 407 | 0.030 |
Why?
|
Alanine Transaminase | 2 | 1999 | 606 | 0.030 |
Why?
|
Biomedical Research | 1 | 2010 | 3463 | 0.030 |
Why?
|
Focus Groups | 1 | 2021 | 1462 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2018 | 1356 | 0.030 |
Why?
|
Drug Hypersensitivity | 1 | 2003 | 923 | 0.030 |
Why?
|
Food Hypersensitivity | 1 | 2002 | 734 | 0.030 |
Why?
|
Endocrinology | 1 | 2000 | 443 | 0.030 |
Why?
|
Anemia | 1 | 2003 | 1517 | 0.030 |
Why?
|
Receptors, Chemokine | 1 | 2017 | 652 | 0.030 |
Why?
|
Rats, Inbred Strains | 2 | 1985 | 2087 | 0.030 |
Why?
|
Clinical Enzyme Tests | 1 | 1993 | 114 | 0.030 |
Why?
|
T-Lymphocytes | 3 | 1988 | 10276 | 0.030 |
Why?
|
Th1 Cells | 1 | 2018 | 1042 | 0.030 |
Why?
|
Adult | 12 | 2018 | 223851 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2408 | 0.030 |
Why?
|
Lipoxygenase Inhibitors | 1 | 1992 | 93 | 0.030 |
Why?
|
Methotrexate | 1 | 1999 | 1723 | 0.030 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1993 | 412 | 0.030 |
Why?
|
Calcium Pyrophosphate | 1 | 1992 | 55 | 0.020 |
Why?
|
Interleukins | 1 | 2017 | 796 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2018 | 1378 | 0.020 |
Why?
|
Indomethacin | 1 | 1992 | 323 | 0.020 |
Why?
|
Prognosis | 2 | 2003 | 30046 | 0.020 |
Why?
|
Freund's Adjuvant | 2 | 1988 | 144 | 0.020 |
Why?
|
Hydroxyurea | 1 | 1992 | 284 | 0.020 |
Why?
|
Rupture, Spontaneous | 1 | 1992 | 365 | 0.020 |
Why?
|
Cyclosporins | 1 | 1991 | 216 | 0.020 |
Why?
|
Crystallization | 1 | 1992 | 520 | 0.020 |
Why?
|
Interferon Regulatory Factors | 1 | 2012 | 271 | 0.020 |
Why?
|
Women's Health | 1 | 2000 | 2081 | 0.020 |
Why?
|
Recovery of Function | 1 | 2001 | 2990 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2007 | 65480 | 0.020 |
Why?
|
Eicosanoids | 1 | 1991 | 284 | 0.020 |
Why?
|
Necrosis | 2 | 1990 | 1620 | 0.020 |
Why?
|
Lymph Nodes | 2 | 1994 | 3473 | 0.020 |
Why?
|
Hand | 1 | 1994 | 913 | 0.020 |
Why?
|
Leg | 1 | 1993 | 1089 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1991 | 1629 | 0.020 |
Why?
|
Reference Values | 1 | 1996 | 4940 | 0.020 |
Why?
|
Toll-Like Receptors | 1 | 2012 | 582 | 0.020 |
Why?
|
Prednisone | 2 | 1991 | 1567 | 0.020 |
Why?
|
Motivation | 1 | 2018 | 2025 | 0.020 |
Why?
|
Diamines | 1 | 1988 | 60 | 0.020 |
Why?
|
Risk Assessment | 2 | 2018 | 24333 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 1994 | 1112 | 0.020 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2009 | 239 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2006 | 15951 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2000 | 3628 | 0.020 |
Why?
|
Mice, Inbred DBA | 1 | 1988 | 624 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2012 | 8055 | 0.020 |
Why?
|
Rats | 4 | 1988 | 23786 | 0.020 |
Why?
|
Laryngeal Diseases | 1 | 1990 | 248 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2001 | 3538 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 1988 | 1163 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 1993 | 1281 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2017 | 2986 | 0.020 |
Why?
|
Pain Threshold | 1 | 2009 | 606 | 0.020 |
Why?
|
Sex Characteristics | 1 | 1996 | 2649 | 0.020 |
Why?
|
Immunoassay | 1 | 2009 | 746 | 0.020 |
Why?
|
Synovial Membrane | 1 | 1988 | 536 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2003 | 59739 | 0.010 |
Why?
|
Hemagglutination Tests | 1 | 1984 | 76 | 0.010 |
Why?
|
Cell Movement | 1 | 2017 | 5216 | 0.010 |
Why?
|
Gout | 1 | 1992 | 621 | 0.010 |
Why?
|
Immunoglobulin mu-Chains | 1 | 1984 | 62 | 0.010 |
Why?
|
Cartilage | 1 | 1988 | 811 | 0.010 |
Why?
|
Chickens | 1 | 1985 | 845 | 0.010 |
Why?
|
Radiography | 1 | 1994 | 6991 | 0.010 |
Why?
|
Cell Line | 2 | 1988 | 15604 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10486 | 0.010 |
Why?
|
Lymphatic System | 1 | 1984 | 251 | 0.010 |
Why?
|
Technetium Tc 99m Medronate | 1 | 1982 | 136 | 0.010 |
Why?
|
Biopsy | 1 | 1994 | 6805 | 0.010 |
Why?
|
Incidence | 1 | 2001 | 21547 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15879 | 0.010 |
Why?
|
Immunization, Passive | 1 | 1984 | 619 | 0.010 |
Why?
|
Species Specificity | 1 | 1985 | 2417 | 0.010 |
Why?
|
Mast Cells | 1 | 1988 | 1406 | 0.010 |
Why?
|
Time Factors | 4 | 1993 | 40261 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9549 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2012 | 2748 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2009 | 3163 | 0.010 |
Why?
|
Liver | 2 | 1999 | 7578 | 0.010 |
Why?
|
Animals | 6 | 2012 | 169335 | 0.010 |
Why?
|
Tarsal Joints | 1 | 1979 | 32 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2017 | 11684 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39394 | 0.010 |
Why?
|
Animals, Newborn | 1 | 1984 | 2683 | 0.010 |
Why?
|
DNA Replication | 1 | 1985 | 1428 | 0.010 |
Why?
|
Immune Tolerance | 2 | 1984 | 2323 | 0.010 |
Why?
|
Hip | 1 | 1979 | 256 | 0.010 |
Why?
|
Knee | 1 | 1979 | 278 | 0.010 |
Why?
|
Double-Blind Method | 2 | 2006 | 12467 | 0.010 |
Why?
|
Nausea | 1 | 1999 | 682 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 18068 | 0.010 |
Why?
|
Ankle | 1 | 1979 | 353 | 0.010 |
Why?
|
Pain Measurement | 1 | 2006 | 3586 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1979 | 1998 | 0.010 |
Why?
|
Retrospective Studies | 2 | 1996 | 81903 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 54962 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 10765 | 0.010 |
Why?
|
Risk Factors | 1 | 2001 | 74976 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 1982 | 1889 | 0.010 |
Why?
|
Mice | 2 | 2012 | 82072 | 0.010 |
Why?
|
Syndrome | 1 | 1979 | 3274 | 0.010 |
Why?
|
Health Status | 1 | 2006 | 4095 | 0.010 |
Why?
|
Diarrhea | 1 | 1999 | 1320 | 0.010 |
Why?
|
Leukotriene B4 | 1 | 1992 | 281 | 0.010 |
Why?
|
Thromboxane B2 | 1 | 1991 | 143 | 0.010 |
Why?
|
Renal Circulation | 1 | 1991 | 291 | 0.010 |
Why?
|
Patient Compliance | 1 | 1999 | 2701 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2009 | 26395 | 0.000 |
Why?
|
Creatinine | 1 | 1991 | 1917 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1988 | 20776 | 0.000 |
Why?
|
Hyperplasia | 1 | 1988 | 1154 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1988 | 2560 | 0.000 |
Why?
|
Xerostomia | 1 | 1984 | 94 | 0.000 |
Why?
|
Leukopenia | 1 | 1984 | 212 | 0.000 |
Why?
|
Skin Ulcer | 1 | 1984 | 130 | 0.000 |
Why?
|
Glomerular Filtration Rate | 1 | 1991 | 2228 | 0.000 |
Why?
|
Anemia, Aplastic | 1 | 1984 | 231 | 0.000 |
Why?
|
Lymphopenia | 1 | 1984 | 300 | 0.000 |
Why?
|
Hypothyroidism | 1 | 1984 | 667 | 0.000 |
Why?
|
Drug Resistance | 1 | 1984 | 1599 | 0.000 |
Why?
|
Blood Transfusion | 1 | 1984 | 1309 | 0.000 |
Why?
|
Radiotherapy | 1 | 1984 | 1506 | 0.000 |
Why?
|
Adipose Tissue | 1 | 1988 | 3335 | 0.000 |
Why?
|
Thrombocytopenia | 1 | 1984 | 1181 | 0.000 |
Why?
|
Kidney | 1 | 1991 | 7058 | 0.000 |
Why?
|
Hypertension | 1 | 1991 | 8617 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1988 | 18354 | 0.000 |
Why?
|